Annual Accounts Payable
$38.86 M
+$3.70 M+10.52%
31 December 2022
Summary:
Mirati Therapeutics annual accounts payable is currently $38.86 million, with the most recent change of +$3.70 million (+10.52%) on 31 December 2022. During the last 3 years, it has risen by +$3.70 million (+10.52%).MRTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$37.96 M
+$5.45 M+16.78%
30 September 2023
Summary:
Mirati Therapeutics quarterly accounts payable is currently $37.96 million, with the most recent change of +$5.45 million (+16.78%) on 30 September 2023.MRTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRTX Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +10.5% | +8.0% |
| 5 y5 years | +137.4% | +131.9% |
MRTX Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | at high | -11.6% |
Mirati Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $37.96 M(+16.8%) |
| June 2023 | - | $32.51 M(+45.6%) |
| Mar 2023 | - | $22.32 M(-42.6%) |
| Dec 2022 | $38.86 M(+10.5%) | $38.86 M(+99.8%) |
| Sept 2022 | - | $19.45 M(-19.8%) |
| June 2022 | - | $24.27 M(-13.1%) |
| Mar 2022 | - | $27.94 M(-20.5%) |
| Dec 2021 | $35.16 M(+94.1%) | $35.16 M(-18.1%) |
| Sept 2021 | - | $42.92 M(+79.8%) |
| June 2021 | - | $23.87 M(+21.8%) |
| Mar 2021 | - | $19.60 M(+8.2%) |
| Dec 2020 | $18.12 M(+10.7%) | $18.12 M(+13.4%) |
| Sept 2020 | - | $15.97 M(-33.7%) |
| June 2020 | - | $24.10 M(+151.4%) |
| Mar 2020 | - | $9.59 M(-41.4%) |
| Dec 2019 | $16.37 M(+91.9%) | $16.37 M(+30.2%) |
| Sept 2019 | - | $12.57 M(+19.6%) |
| June 2019 | - | $10.51 M(+4.4%) |
| Mar 2019 | - | $10.07 M(+18.0%) |
| Dec 2018 | $8.53 M(+96.4%) | $8.53 M(+24.7%) |
| Sept 2018 | - | $6.84 M(+60.4%) |
| June 2018 | - | $4.27 M(-9.8%) |
| Mar 2018 | - | $4.73 M(+8.9%) |
| Dec 2017 | $4.34 M(-31.0%) | $4.34 M(+59.2%) |
| Sept 2017 | - | $2.73 M(-31.3%) |
| June 2017 | - | $3.97 M(+15.2%) |
| Mar 2017 | - | $3.45 M(-45.2%) |
| Dec 2016 | $6.30 M | $6.30 M(+96.1%) |
| Sept 2016 | - | $3.21 M(-27.8%) |
| June 2016 | - | $4.45 M(+37.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | $3.24 M(+53.8%) |
| Dec 2015 | $2.10 M(+27.1%) | $2.10 M(-35.2%) |
| Sept 2015 | - | $3.25 M(+79.2%) |
| June 2015 | - | $1.81 M(+42.6%) |
| Mar 2015 | - | $1.27 M(-23.2%) |
| Dec 2014 | $1.66 M(+27.1%) | $1.66 M(-14.4%) |
| Sept 2014 | - | $1.93 M(+100.8%) |
| June 2014 | - | $963.00 K(+76.4%) |
| Mar 2014 | - | $546.00 K(-58.1%) |
| Dec 2013 | $1.30 M(-25.7%) | $1.30 M(-34.9%) |
| Sept 2013 | - | $2.00 M(+42.4%) |
| June 2013 | - | $1.41 M(+17.4%) |
| Mar 2013 | - | $1.20 M(-31.7%) |
| Dec 2012 | $1.75 M(+129.6%) | $1.75 M(+129.6%) |
| Dec 2011 | $763.00 K(-82.5%) | $763.00 K(-89.7%) |
| Sept 2008 | - | $7.38 M(-7.7%) |
| June 2008 | - | $7.99 M(+7.3%) |
| Mar 2008 | - | $7.44 M(+14.5%) |
| Sept 2007 | - | $6.50 M(+54.5%) |
| June 2007 | - | $4.21 M(+14.3%) |
| Mar 2007 | - | $3.68 M(-15.4%) |
| Dec 2006 | $4.35 M(+30.8%) | $4.35 M(+30.2%) |
| Sept 2006 | - | $3.34 M(+11.6%) |
| June 2006 | - | $3.00 M(+4.3%) |
| Mar 2006 | - | $2.87 M(-13.6%) |
| Dec 2005 | $3.33 M(+42.0%) | $3.33 M(+21.2%) |
| Sept 2005 | - | $2.75 M(+16.5%) |
| June 2005 | - | $2.36 M(+4.5%) |
| Mar 2005 | - | $2.26 M |
| Dec 2004 | $2.34 M | - |
FAQ
- What is Mirati Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Mirati Therapeutics?
- What is Mirati Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Mirati Therapeutics?
What is Mirati Therapeutics annual accounts payable?
The current annual accounts payable of MRTX is $38.86 M
What is the all time high annual accounts payable for Mirati Therapeutics?
Mirati Therapeutics all-time high annual accounts payable is $38.86 M
What is Mirati Therapeutics quarterly accounts payable?
The current quarterly accounts payable of MRTX is $37.96 M
What is the all time high quarterly accounts payable for Mirati Therapeutics?
Mirati Therapeutics all-time high quarterly accounts payable is $42.92 M